Status:
COMPLETED
Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
The Children's Tumor Foundation
Conditions:
Neurofibromatosis
Neurofibromatosis I
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study tests the efficacy of an 8-week, Skype-based, group resiliency training intervention (The Relaxation Response Resiliency Program) for improving psychological stress in patients with Neurofi...
Eligibility Criteria
Inclusion
- Age 18 or older
- Can read and speak English at or above the 6th grade level
- Diagnosis of neurofibromatosis type 1, neurofibromatosis type 2, or schwannomatosis
Exclusion
- Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality)
- Recent (within past 3 months) change in antidepressant medication
- Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months.
- Unable or unwilling to sign the informed consent documents
- Unable or unwilling to complete psychological assessments online via the REDCap system.
- Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT02298270
Start Date
March 1 2014
End Date
July 1 2015
Last Update
June 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02140